1. CT-guided ozone-mediated lumbar-renal sympathetic denervation for resistant hypertension treatment: A pilot single-arm clinical trial.
- Author
-
Li L, Liu J, Huang B, Zhang Y, Zeng F, Tian P, Chen X, Li B, Wang Y, Yang H, Xiao X, Chen S, Jiang P, Wang J, and Huang Y
- Subjects
- Humans, Male, Female, Aged, Middle Aged, Pilot Projects, Treatment Outcome, Time Factors, Blood Pressure Monitoring, Ambulatory, Radiography, Interventional, Sympathectomy adverse effects, Sympathectomy methods, China, Ozone administration & dosage, Ozone adverse effects, Hypertension physiopathology, Hypertension drug therapy, Hypertension diagnosis, Hypertension surgery, Kidney innervation, Blood Pressure drug effects, Antihypertensive Agents adverse effects, Antihypertensive Agents therapeutic use, Antihypertensive Agents administration & dosage, Drug Resistance
- Abstract
Background: Renal sympathetic denervation (RDN) reduces blood pressure (BP)., Methods: This single-arm open-label study enrolled patients with resistant hypertension (RH) and treat them by CT-guided ozone mediated lumbar-renal sympathetic denervation (L-RDN). The primary endpoint was to assess the changes of BP over 24-h ambulatory BP monitoring (ABPM) and to evaluate the anti-hypertensive medication burden (AHMB) at 3-month follow-up. This study was registered in Chictr.org.cn (ChiCTR2300071375)., Results: 17 patients (mean age 65.12 ± 10.77 years) with AHMB of 4.12 ± 1.11 were enrolled. After the procedure, 7 patients (46.7 %) matched the criteria for antihypertensive medication reduction. The AHMB decreased to 3.87 ± 0.96 for the whole objectives and from 3.87 ± 0.96 to 3.55 ± 0.78 for patients with normal baseline renal function. On top of the lessened AHMB, L-RDN further reduced morning systolic BP (SBP) by -8.6 ± 4.0 mmHg (p = 0.034) and diastolic BP (DBP) by -4.6 ± 2.1 mmHg (p = 0.032) for all participants and morning SBP by -13.2 ± 3.6 mmHg (p < 0.001), morning DBP by -6.2 ± 2.4 mmHg (p = 0.011) and daytime SBP by -4.1 ± 1.6 mmHg (p = 0.009) for those with normal baseline renal function at 3-month of follow-up. No adverse events were reported intra- and post operation., Conclusions: CT-guided ozone-mediated L-RDN might be an innovative approach of RDN for treating RH. Confirmatory studies are warranted., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF